Month

December 2018
Brief review of several clinically relevant updates: CDC opioid guideline & MME calculator mobile app DOT final rule on diabetes for interstate commerce 2018 ACC/AHA lipid guideline release
Read More
Baloxavir Marboxil (Xofluza): New FDA Approval for Influenza Treatment1,2,3,4 Baloxavir marboxil (Xofluza) was approved by the FDA on October 24, 2018 to treat influenza within 48 hours of onset of influenza symptoms. This approval has created many questions regarding the new product. The key points listed below will provide a general overview of important information...
Read More